首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1604179

全球支氣管內超音波活體組織切片市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Endobronchial Ultrasound Biopsy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年11月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球支氣管內超音波活體組織切片市場需求預計將從 2023 年的 6.9464 億美元達到 2032 年的近 11.4208 億美元，2024-2032 年研究期間複合年成長率為 5.68%。

支氣管內超音波活體組織切片 (EBUS) 是一種微創診斷程序，用於對胸部淋巴結和腫塊進行可視化和活體組織切片，特別是對於疑似肺癌患者。該技術涉及使用支氣管內超音波鏡，它將支氣管鏡檢查與超音波成像相結合。示波器透過嘴巴或鼻子插入支氣管，可以即時觀察周圍的結構。該設備產生的超音波可提供淋巴結和其他組織的詳細影像，從而實現異常區域的精確定位和引導活體組織切片。與傳統侵入性方法相比，該方法在準確性、安全性和患者舒適度方面具有顯著優勢，使其成為胸部惡性腫瘤早期診斷和分期的重要工具。

市場動態

全球肺癌發生率不斷上升推動了支氣管內超音波活體組織切片 (EBUS) 市場的發展，這需要先進的診斷工具來進行早期檢測和準確分期。 EBUS 為更具侵入性的診斷程序提供了一種微創替代方案，因其精確性和減少患者不適而成為臨床醫生的首選。此外，EBUS 技術的進步，例如提高的成像解析度和增強的活體組織切片能力，正在推動市場成長。整合先進的針引導系統和即時成像增強功能等創新提高了診斷準確性和程序效率。另一個關鍵因素是人們對早期肺癌檢測益處的認知不斷提高，從而增加了已開發市場和新興市場對 EBUS 手術的需求。新興經濟體不斷擴大的醫療基礎設施和不斷增加的腫瘤診斷投資也為市場成長提供了巨大的機會。此外，EBUS 與其他影像方式（例如 PET 掃描）相結合的日益普及，透過提供全面的診斷解決方案進一步支持其市場擴張。具有增強功能的下一代 EBUS 系統的持續開發有望改善患者治療效果和手術成功率，推動進一步採用和市場成長。然而，高昂的設備成本和缺乏訓練有素的專業人員可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對支氣管內超音波活體組織切片全球市場的每個細分市場進行包容性評估。支氣管內超音波活體組織切片行業的成長和趨勢為本研究提供了整體方法。

市場區隔

支氣管內超音波活體組織切片市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

切片鉗
細胞學刷
切片針
經支氣管抽吸針
噴霧導管
其他

按申請

癌症診斷
感染診斷
其他

按最終用戶

醫院
門診手術中心
癌症專科診所
診斷中心
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲支氣管內超音波活體組織切片市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。支氣管內超音波切片市場的主要參與者包括奧林巴斯公司、美敦力公司、庫克醫療公司、Conmed公司、Clinodevice、Medi-Globe GmbH、波士頓科學公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：支氣管內超音波切片公司的競爭格局

支氣管內超音波切片市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Olympus Corporation

公司概況
公司收入
產品
最新動態

Medtronic

公司概況
公司收入
產品
最新動態

Cook Medical

公司概況
公司收入
產品
最新動態

Conmed Corporation

公司概況
公司收入
產品
最新動態

Clinodevice

公司概況
公司收入
產品
最新動態

Medi-Globe GmbH

公司概況
公司收入
產品
最新動態

Boston Scientific Corporation

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115452

The global demand for Endobronchial Ultrasound Biopsy Market is presumed to reach the market size of nearly USD 1142.08 Million by 2032 from USD 694.64 Million in 2023 with a CAGR of 5.68% under the study period 2024-2032.

Endobronchial ultrasound biopsy (EBUS) is a minimally invasive diagnostic procedure used to visualize and biopsy lymph nodes and masses in the chest, particularly in patients with suspected lung cancer. The technique involves using an endobronchial ultrasound scope, which combines bronchoscopy with ultrasound imaging. The scope is inserted through the mouth or nose into the bronchi, allowing real-time visualization of the surrounding structures. Ultrasound waves generated by the device provide detailed images of lymph nodes and other tissues, enabling precise localization and guided biopsy of abnormal areas. This approach offers significant advantages in accuracy, safety, and patient comfort compared to traditional invasive methods, making it an essential tool for early diagnosis and staging of thoracic malignancies.

MARKET DYNAMICS

The endobronchial ultrasound biopsy (EBUS) market is propelled by the increasing incidence of lung cancer globally, which necessitates advanced diagnostic tools for early detection and accurate staging. EBUS offers a minimally invasive alternative to more invasive diagnostic procedures, making it a preferred choice among clinicians for its precision and reduced patient discomfort. Additionally, advancements in EBUS technology, such as improved imaging resolution and enhanced biopsy capabilities, are driving market growth. Innovations like integrating advanced needle guidance systems and real-time imaging enhancements improve diagnostic accuracy and procedural efficiency. Another crucial factor is the rising awareness of early lung cancer detection benefits, boosting demand for EBUS procedures in both developed and emerging markets. The expanding healthcare infrastructure and increasing investments in oncology diagnostics in emerging economies also present significant opportunities for market growth. Moreover, the growing adoption of EBUS in combination with other imaging modalities, such as PET scans, further supports its market expansion by providing comprehensive diagnostic solutions. The ongoing development of next-generation EBUS systems with enhanced features promises to improve patient outcomes and procedural success, driving further adoption and market growth. However, high equipment costs and a shortage of trained professionals can hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Endobronchial Ultrasound Biopsy. The growth and trends of Endobronchial Ultrasound Biopsy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Endobronchial Ultrasound Biopsy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Others

By Application

Cancer Diagnosis
Infection Diagnosis
Others

By End-user

Hospitals
Ambulatory Surgical Centers
Cancer Specialty Clinics
Diagnostics Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Endobronchial Ultrasound Biopsy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Endobronchial Ultrasound Biopsy market include Olympus Corporation, Medtronic, Cook Medical, Conmed Corporation, Clinodevice, Medi-Globe GmbH, Boston Scientific Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ENDOBRONCHIAL ULTRASOUND BIOPSY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Biopsy Forceps Historic and Forecast Sales By Regions
5.4. Cytology Brushes Historic and Forecast Sales By Regions
5.5. Biopsy Needles Historic and Forecast Sales By Regions
5.6. Transbronchial Aspiration Needles Historic and Forecast Sales By Regions
5.7. Spray Catheters Historic and Forecast Sales By Regions
5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Cancer Diagnosis Historic and Forecast Sales By Regions
6.4. Infection Diagnosis Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.5. Cancer Specialty Clinics Historic and Forecast Sales By Regions
7.6. Diagnostics Centers Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ENDOBRONCHIAL ULTRASOUND BIOPSY COMPANIES

9.1. Endobronchial Ultrasound Biopsy Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ENDOBRONCHIAL ULTRASOUND BIOPSY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Olympus Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Medtronic
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Cook Medical
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Conmed Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Clinodevice
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Medi-Globe GmbH
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Boston Scientific Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments